Dapagliflozin Improves the Clinical Outcomes of Patients with Chronic Kidney Disease and Albuminuria

被引：0
|
作者：
Patrick, Stephanie A. [1 ]
Dabal, Tracey D. [1 ]
Jackson, Christopher D. [1 ]
Halalau, Alexandra [1 ]
机构：
[1] UTHSC Internal Med Residency, Memphis, TN 38163 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2021年 / 36卷 / 09期
关键词：
D O I：
10.1007/s11606-021-06871-w
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：2915 / 2917
页数：3
相关论文
共 50 条
  • [31] Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD)
    McMurray, John J.
    Wheeler, David C.
    Stefansson, Bergur V.
    Rotter, Ricardo Correa
    Chertow, Glenn M.
    Greene, Tom
    Hou, Fan Fan
    Lindberg, Magnus B.
    Rossing, Peter
    Sjostrom, David
    Toto, Robert D.
    Langkilde, Anna Maria
    Heerspink, Hiddo J. Lambers
    CIRCULATION, 2020, 142 (24) : E482 - E483
  • [32] The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: a randomized placebo-controlled clinical trial
    Gansevoort, Ron T.
    Wheeler, David C.
    Deben, Francisco Martinez
    Speeckaert, Marijn
    Thomas, Dirk
    Berger, Mario
    Klein, Stefan
    Friedrichs, Frauke
    Paraschin, Karen
    Schmieder, Roland E.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025,
  • [33] DAPAGLIFLOZIN DECREASES ALBUMINURIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH AND WITHOUT TYPE 2 DIABETES: INSIGHTS FROM THE DAPA-CKD TRIAL
    Jong, Niels
    Chertow, Glenn
    Hou, Fan Fan
    McMurray, John
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, David
    Stefansson, Bergur
    Toto, Robert
    Langkilde, Anna Maria
    Wheeler, David C.
    Heerspink, Hiddo Lambers
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [34] Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan
    Tangri, Navdeep
    Rastogi, Anjay
    Nekeman-Nan, Cassandra
    Hong, Lai San
    Ozaki, Asuka
    Franzen, Stefan
    Sofue, Tadashi
    ADVANCES IN THERAPY, 2024, 41 (03) : 1151 - 1167
  • [35] Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan
    Navdeep Tangri
    Anjay Rastogi
    Cassandra Nekeman-Nan
    Lai San Hong
    Asuka Ozaki
    Stefan Franzén
    Tadashi Sofue
    Advances in Therapy, 2024, 41 : 1151 - 1167
  • [36] Dapagliflozin and the Incidence of Type 2 Diabetes in Patients with Chronic Kidney Disease
    Rossing, Peter
    Vart, Priya
    Chertow, Glenn M.
    Hou, Fan Fan
    Jongs, Niels
    Mcmurray, John J.
    Correa-Rotter, Ricardo
    Stefansson, Bergur
    Toto, Robert D.
    Langkilde, Anna Maria
    Wheeler, David C.
    Heerspink, Hiddo L.
    DIABETES, 2021, 70
  • [37] Safety Profile and Effectiveness of Dapagliflozin in Pediatric Patients with Chronic Kidney Disease
    Van Reeth, Olil
    Caliment, Ancuta
    Garcia, Isabel de la Fuente
    Niel, Olivier
    AMERICAN JOURNAL OF NEPHROLOGY, 2024, 55 (04) : 463 - 467
  • [38] SHORT-TERM EFFICACY OF DAPAGLIFLOZIN FOR CHRONIC KIDNEY DISEASE PATIENTS
    Nakai, Kentaro
    Hara, Yuichiro
    Inoue, Megumi
    Shukuri, Tomoya
    Hara, Masatoshi
    Nakagawa, Kaneyasu
    Tokumoto, Masanori
    JOURNAL OF HYPERTENSION, 2023, 41 : E420 - E420
  • [39] Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease
    Viasus, Diego
    Garcia-Vidal, Carolina
    Cruzado, Josep M.
    Adamuz, Jordi
    Verdaguer, Ricard
    Manresa, Frederic
    Dorca, Jordi
    Gudiol, Francesc
    Carratala, Jordi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (09) : 2899 - U1510
  • [40] CLINICAL OUTCOMES IN NSW PATIENTS ADMITTED WITH AMI AND CHRONIC KIDNEY DISEASE
    Kotwal, S.
    Ranasinghe
    Foote, C.
    Wang, A.
    Cass, A.
    Gallagher, M.
    NEPHROLOGY, 2012, 17 : 28 - 29
12345